DJIA 18,096.90 -106.47 -0.58%
NASDAQ 4,967.14 -12.76 -0.26%
S&P 500 2,098.53 -9.25 -0.44%
market minute promo


company name or ticker

3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir

For companies involved in the development of drugs, a PDUFA decision will meaningfully impact their stocks. With this in mind, there are several PDUFA decisions in upcoming months to watch for.

Spectrum - Pullback An Opportunity To Jump In

Mallinckrodt Earnings Beat, Shares Dip on Low Revs - Analyst Blog

Shares Continue to fall on Emergent BioSolutions' Wider Loss - Analyst Blog

Infinity Pharma Down on Wider-than-Expected Loss - Analyst Blog

Spectrum Pharmaceuticals' (SPPI) CEO Rajesh Shrotriya on Q1 2014 Results - Earnings Call Transcript

Spectrum Pharmaceuticals (SPPI) Q1 2014 Results - Earnings Call Webcast

ARIAD's Q1 Loss Narrows - Analyst Blog

Is A Short Squeeze Ahead for Spectrum Pharmaceuticals (SPPI)? - Tale of the Tape

Is A Short Squeeze Ahead for Spectrum Pharmaceuticals (SPPI)? - Tale of the Tape

Clinical Winners and Losers: Spectrum Pharmaceuticals and Cytokinetics

Find out which biotech posted the best, and worst, clinical results last week.
See More Articles...